Illumina (ILMN) revenue breakdown
By segment, Sequencing is the largest at 92% of fiscal 2025 revenue, growing -2% a year over 3 years.
By product, Consumables is the largest at 74% of fiscal 2025 revenue, growing 8% a year over 8 years.
Revenue by segment
Fiscal years, as Illumina reports them in its 10-K filings; fiscal 2025 total $4.3B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Sequencing | — | — | — | — | — | $4.2B | $4.1B | $4.0B | $4.0B | 92% |
| Microarray | — | — | — | — | — | $413M | $392M | $379M | $358M | 8% |
| Sequencing | — | — | — | — | $4.1B | — | — | — | — | — |
| Core Illumina | $2.8B | $3.3B | — | — | — | — | — | — | — | — |
| Sequencing | — | — | $3.1B | $2.9B | — | — | — | — | — | — |
| Microarray | — | — | — | — | $417M | — | — | — | — | — |
| Microarray | — | — | $475M | $360M | — | — | — | — | — | — |
| Helix | $6M | $10M | — | — | — | — | — | — | — | — |
Revenue by product
Fiscal years, as Illumina reports them in its 10-K filings; fiscal 2025 total $4.3B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | — | $1.8B | $2.2B | $2.4B | $2.3B | $3.2B | $3.2B | $3.1B | $3.2B | $3.2B | 74% |
| Service | $366M | $463M | $584M | $614M | $504M | $558M | $631M | $717M | $716M | $634M | 15% |
| Instruments | — | $518M | $572M | $537M | $431M | $751M | $728M | $704M | $501M | $482M | 11% |
| Product revenue | $2.0B | — | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Illumina reports them in its 10-K filings; fiscal 2025 total $4.3B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $1.4B | $1.6B | $1.9B | $2.0B | $1.7B | $2.4B | $2.5B | $2.5B | $2.4B | $2.4B | 55% |
| Europe | $575M | $653M | $851M | $933M | $886M | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | 29% |
| Asia-Pacific, Middle East and Africa | — | — | — | — | — | $517M | $544M | $459M | $438M | $430M | 10% |
| China | — | $292M | $365M | $372M | $342M | $502M | $472M | $384M | $308M | $243M | 6% |
| Asia-Pacific | $456M | $222M | $253M | $268M | $267M | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ILMN.
Open ILMN in InvestinglyQuestions
Where does Illumina make its money?
In fiscal 2025, by segment: Sequencing $4.0B, Microarray $358M.
From Illumina's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.